| Jane M Kersten, CAA | |
|
600 Highland Ave, Madison, WI 53792-0001 | |
| (608) 263-8100 | |
| Not Available |
| Full Name | Jane M Kersten |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 4 Years |
| Location | 600 Highland Ave, Madison, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255929063 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 174 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Wi Hospitals & Clinics Authority | Madison, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Wisconsin Medical Foundation Inc | 6608785464 | 2164 |
News Archive
It was reported that the volume of the brain areas such as the superior temporal gyrus and anterior cingulate cortex reduces in schizophrenia but a precise change of three-dimensional structure of neuron has remained unclear.
Six key humanities programs at the University of Oklahoma will benefit from a $500,000 award from the National Endowment for the Humanities, the largest ever total grant from the NEH for OU.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
News outlets report on developments regarding the New York state Medicaid program.
› Verified 3 days ago
| Entity Name | University Of Wisconsin Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598784555 PECOS PAC ID: 6608785464 Enrollment ID: O20031111000435 |
News Archive
It was reported that the volume of the brain areas such as the superior temporal gyrus and anterior cingulate cortex reduces in schizophrenia but a precise change of three-dimensional structure of neuron has remained unclear.
Six key humanities programs at the University of Oklahoma will benefit from a $500,000 award from the National Endowment for the Humanities, the largest ever total grant from the NEH for OU.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
News outlets report on developments regarding the New York state Medicaid program.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jane M Kersten, CAA 7974 Uw Health Ct, Middleton, WI 53562-5531 Ph: () - | Jane M Kersten, CAA 600 Highland Ave, Madison, WI 53792-0001 Ph: (608) 263-8100 |
News Archive
It was reported that the volume of the brain areas such as the superior temporal gyrus and anterior cingulate cortex reduces in schizophrenia but a precise change of three-dimensional structure of neuron has remained unclear.
Six key humanities programs at the University of Oklahoma will benefit from a $500,000 award from the National Endowment for the Humanities, the largest ever total grant from the NEH for OU.
Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.
News outlets report on developments regarding the New York state Medicaid program.
› Verified 3 days ago
Margaret O Schessler, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8100 Fax: 608-263-8111 | |
Mrs. Laura Brichler Wyatt, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8100 Fax: 608-226-3811 | |
Nikki L Brechtel, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8100 Fax: 608-263-0575 | |
Muhammad Hassan, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8100 Fax: 608-262-6247 | |
Kelly Erin Mcclanahan, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8100 Fax: 608-262-6247 | |
Taylor Lewis, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8100 Fax: 608-262-6247 | |
Michael D Devine, AAC Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8100 Fax: 608-263-0575 |